Gastrointestinal Stromal Tumor
Oncology·MeSH: Gastrointestinal Stromal Tumors
Prevalence
30.0 / 100K
7 drugs in development·5 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Phase 2(1)
| Drug | Company |
|---|---|
| Bezuclastinib | Cogent Biosciences, Inc. (COGT) |
Phase 1(2)
Phase 1/Phase 2(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Gastrointestinal Stromal Tumor?
BioSniper tracks 7 drugs in development for Gastrointestinal Stromal Tumor across 5 companies.
How many clinical trials target Gastrointestinal Stromal Tumor?
There are 2 clinical trials targeting Gastrointestinal Stromal Tumor tracked by BioSniper.
What is the prevalence of Gastrointestinal Stromal Tumor?
The estimated prevalence of Gastrointestinal Stromal Tumor is approximately 30.0 per 100,000 population.
Deep-dive into Gastrointestinal Stromal Tumor
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis